Clinical Trials & Medical Discoveries The most recent news and results from scientific and medical research, covering all aspects of healthcare, including testing, diagnosis, and treatment. Stay up-to-date on the latest medical discoveries and breakthroughs with announcements of new products to be tested, upcoming clinical trials and studies, and newly published results. Also included are updates regarding funding decisions, company performance, and legal news.

Latest

May 17, 2018, 19:00 ET Keck School of Medicine of USC urologists present latest research at the American Urological Association 2018 annual meeting

From robotics and machine learning to new applications for MRIs, Keck School of Medicine of USC scientists will present research highlighting the...


May 17, 2018, 16:00 ET Celularity and New York Medical College Partner on a Breakthrough Study to Treat RDEB with Human Placental Derived Stem Cells

Celularity, Inc. ("Celularity"), a biotechnology company that produces lifesaving cell therapies from the postpartum placenta, announces that it is...


May 17, 2018, 14:42 ET Lustgarten-Funded Researcher Unlocks How Pancreatic Cancer Metastasizes to the Liver

Lustgarten Foundation Distinguished Scholar Douglas Fearon, M.D., a professor at Cold Spring Harbor Laboratory (CSHL), has discovered how...


May 17, 2018, 14:32 ET Department of Defense Announces Lupus Research Program Awardees

The Department of Defense (DOD) today announced the award of nearly $5 million to 13 innovative and impactful lupus research projects through its...


May 17, 2018, 14:00 ET How pancreatic cancer spreads after surgery

Scientists at Cold Spring Harbor Laboratory (CSHL) have solved a mystery about how pancreatic cancer spreads following surgery in patients whose...


May 17, 2018, 14:00 ET Glenmark Pharmaceuticals Announces Oral Presentation of New Data on GBR 830, an Investigational, Anti-OX40 Monoclonal Antibody, at the International Investigative Dermatology Meeting

Glenmark Pharmaceuticals, a global pharmaceutical company, today announced data from a Phase 2a, proof-of-concept study of GBR 830, an...


May 17, 2018, 13:37 ET Agenus to Present Clinical Data on Lead Programs at ASCO 2018

Agenus Inc. (NASDAQ: AGEN), an immuno-oncology company with a pipeline of immune checkpoint antibodies, cancer vaccines, and adoptive cell...


May 17, 2018, 13:11 ET Sanofi: Accelerating Future Breakthroughs Through Clinical Trials -- Part 2 of 3

For biopharmaceutical companies looking to streamline the clinical trial process, "big data" can be a big challenge. From complex genomics to the...


May 17, 2018, 12:30 ET AUA Releases Updates to Clinical Guideline on Castration-Resistant Prostate Cancer

Today, the American Urological Association (AUA), a leading global urology association, announced updates to its Castration-Resistant Prostate...


May 17, 2018, 10:14 ET Protagonist Therapeutics Announces Two Oral Presentations Accepted for 23rd Congress of the European Hematology Association

Protagonist Therapeutics, Inc. (Nasdaq: PTGX) today announced that clinical and preclinical abstracts for PTG-300, the Company's injectable...


May 17, 2018, 10:11 ET Mirasol®-Treated Platelets Show No Clinical Difference in Reducing Bleeding From Conventional Platelets in Plasma

The results of the PREPAReS clinical trial were published today in Blood, the official journal of the American Society of Hematology. The trial...


May 17, 2018, 10:00 ET AUA Releases New Clinical Guideline for Surgical Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia

Today, the American Urological Association (AUA), a leading global urology association, released a new clinical guideline on the surgical...


May 17, 2018, 09:51 ET Boston Biomedical, Inc. Announces Presentations for Investigational Agents Napabucasin and DSP-7888 (ombipepimut-S*) to be Featured at ASCO 2018

Boston Biomedical, Inc., an industry leader in the development of novel cancer therapeutics, today announced that it will feature several studies...


May 17, 2018, 09:35 ET Novartis data at ASCO and EHA reinforce company's commitment to reimagining cancer

Novartis will present data from across its oncology portfolio at the upcoming 54th Annual Meeting of the American Society of Clinical Oncology...


May 17, 2018, 09:15 ET BioLineRx to Present Overall Survival Data at EHA from Phase 2a Study of BL-8040 in r/r AML Patients

BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a clinical-stage biopharmaceutical company focused on oncology and immunology, announced today that it...


May 17, 2018, 09:01 ET Forty Seven, Inc. to Present Preliminary Data from its Ongoing Phase 1 Clinical Trial of 5F9 in Acute Myeloid Leukemia at the 23rd Congress of the European Hematology Association (EHA)

Forty Seven, Inc., a clinical-stage immuno-oncology company focused on developing therapies to activate macrophages in the fight against...


May 17, 2018, 09:00 ET CytRx Corporation Highlights NantCell Inc's Aldoxorubicin Clinical Data to be Presented at the American Society of Clinical Oncology 2018 Annual Meeting

CytRx Corporation (NASDAQ: CYTR), a biopharmaceutical research and development company specializing in oncology, today highlighted that clinical...


May 17, 2018, 09:00 ET BioLineRx Reports Results of Phase 2 Study for BL-8040 Monotherapy in Stem Cell Mobilization for Allogeneic Bone Marrow Transplantation

BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a clinical-stage biopharmaceutical company focused on oncology and immunology, announced today positive...


May 17, 2018, 09:00 ET Blueprint Medicines Announces Data Presentations at Upcoming ASCO and EHA Meetings Supporting Plans for Rapid Development of Avapritinib in Patients with Gastrointestinal Stromal Tumors and Systemic Mastocytosis

Blueprint Medicines Corporation (NASDAQ: BPMC), a leader in discovering and developing targeted kinase medicines for patients with genomically...


May 17, 2018, 08:45 ET MabVax Therapeutics Receives U.S. Patent for Fully Human Antibodies Targeting the Antigen GD2 Expressed on Sarcoma, Melanoma, and Neuroblastoma

MabVax Therapeutics Holdings, Inc. (Nasdaq: MBVX), a clinical-stage biotechnology company with a fully human antibody discovery platform focused on...


May 17, 2018, 08:30 ET PharmaMar Announces Data Presentations For Both Its Molecules Yondelis® and Lurbinectedin at ASCO 2018

During the Congress of the American Society of Clinical Oncology (ASCO) that will be held form the 1st to the 5th of June in Chicago (USA),...


May 17, 2018, 08:08 ET Eisai Announces Data at ASCO 2018 Annual Meeting Showcasing LENVIMA® (lenvatinib) and KEYTRUDA® (pembrolizumab) Combination Therapy Under Strategic Oncology Collaboration with Merck

Eisai Inc. today announced the presentation of new data and analyses at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting from...


May 17, 2018, 08:00 ET Trovagene Announces Completion of First Dosing Cohort of Patients in Ongoing Phase 1b/2 Trial of PCM-075 in Acute Myeloid Leukemia

Trovagene, Inc. (NASDAQ: TROV), a clinical-stage oncology therapeutics company, developing targeted therapeutics for the treatment of hematologic...


May 17, 2018, 07:30 ET Clinical phase II results indicate that PMZ-2010 (centhaquin) is a novel highly effective resuscitative agent for hypovolemic shock

Pharmazz, Inc. is pleased to announce interim analysis of a prospective, multi-centric, randomized, double-blind, parallel, saline controlled phase...


May 17, 2018, 07:00 ET Syndax Announces Updated Results from Phase 2 ENCORE 601 Trial of Entinostat in Combination with KEYTRUDA® (pembrolizumab)

Syndax Pharmaceuticals, Inc. ("Syndax," the "Company" or "we") (Nasdaq: SNDX), a clinical stage biopharmaceutical company developing an innovative...